Cervical Cancer Screening: Older Than 65 Years

Some types of human papillomavirus (HPV), the most common sexually transmitted viral infection, are high risk and can cause cervical cancer. Screening options for the prevention and early detection of cervical cancer depend on the age of the individual and may include cytology, cotesting, and primary high-risk HPV (hrHPV) testing.

Refer to ARUP Laboratories’ test offerings below.

ARUP Laboratory Tests

Cytology, ThinPrep Pap Test and Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Nucleic Acid Amplification (NAA), ThinPrep (for routine co-testing in women over 30) 2000136

Method

Microscopy

Cytology, ThinPrep Pap Test 2000137

Method

Microscopy

Cytology, ThinPrep Pap Test with Reflex to Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Nucleic Acid Amplification (NAA), ThinPrep 2000138

Method

Microscopy

Cytology, SurePath Liquid-Based Pap Test 2000134

Method

Microscopy

Cytology, SurePath Liquid-Based Pap Test and Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by PCR, SurePath. (for routine co-testing in women over 30) 2000133

Method

Microscopy

Cytology, SurePath Liquid-Based Pap Test with Reflex to Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by PCR, SurePath 2000135

Method

Microscopy

Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by PCR, SurePath 2011933

Method

Qualitative Polymerase Chain Reaction

Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Nucleic Acid Amplification (NAA), ThinPrep 3003005

Method

Qualitative Nucleic Acid Amplification (NAA)

Having trouble viewing the algorithm? Go directly to the PDF